Özcan EREL, Ali Turhan ÇAĞLAR, Aykan YÜCEL, Sibel ÖZLER, Merve ERGİN, Nuri DANIŞMAN, Dilek UYGUR, Efser ÖZTAŞ, Başak GÜMÜŞ GÜLER

Decreased oxidative stress may contribute to the disease process in placenta accreta

Background/aim: The main aim of this study was to investigate serum total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and arylesterase levels in pregnant women with placenta accreta and to compare those with age-matched healthy pregnant women. Materials and methods: A total of 27 pregnant women who had clinically and pathologically proven placenta accreta and 30 age- and BMI- matched healthy pregnant women were enrolled in this case control study. Maternal serum TOS, TAS, OSI, and arylesterase levels were evaluated using logistic regression analysis to determine if there was an association with abnormal placental invasion or not. Results: Decreased OSI (OR= 0.999, 95%CI: 0.998 1.000, P = 0.035) and increased arylesterase levels (OR= 0.981, 95%CI: 0.970 0.993, P = 0.001) were significantly associated with the presence of placenta accreta. Maternal serum TOS, TAS, OSI, and arylesterase levels were not predictive for adverse perinatal outcomes (P > 0.05). Conclusions: Decreased OSI and increased arylesterase levels are significantly associated with placenta accreta and may contribute to the abnormal invasion process.

PDF

___

1. Belfort MA, Publications Committee Society for MaternalFetal Medicine. Placenta accreta. Am J Obstet Gynecol 2010; 203: 430-439.
2. OBrien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996; 175: 1632-1638.
3. Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol 2008; 61: 1243-1246.
4. Al-Khan A, Aye IL, Barsoum I, Borbely A, Cebral E, Cerchi G, Clifton VL, Collins S, Cotechini T, Davey A et al. IFPA Meeting 2010 Workshops Report II: Placental pathology; trophoblast invasion; fetal sex; parasites and the placenta; decidua and embryonic or fetal loss; trophoblast differentiation and syncytialisation. Placenta 2011; 32: S90-99.
5. Myatt L. Role of placenta in preeclampsia. Endocrine 2002; 19: 103-111.
6. Barut F, Barut A, Gun BD, Kandemir NO, Harma MI, Harma M, Aktunc E, Ozdamar SO. Intrauterine growth restriction and placental angiogenesis. Diagn Pathol 2010; 5: 24.
7. Pinar H, Carpenter M. Placenta and umbilical cord abnormalities seen with stillbirth. Clin Obstet Gynecol 2010; 53: 656-672.
8. Manolea MM, Dijmarescu AL, Popescu FC, Novac MB, DiŢescu D. Evaluation of the implantation site morphology in spontaneous abortion. Rom J Morphol Embryol 2015; 56: 125- 131.
9. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000; 157: 2111-2122.
10. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122: 369-382.
11. Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int 2015; 2015: 814543.
12. Ahmed A, Kilby MD. Placental insufficiency: hypoxia or hyperoxia? Lancet 1997; 350: 826-827.
13. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen-a review. Placenta 2000; 21 Suppl A: S16-24.
14. Fox H. Placenta accreta 1945-1969. Obstet Gynecol Surv 1972; 27: 475-490.
15. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111.
16. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
17. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006; 12: 747-755.
18. Mert I, Oruc AS, Yuksel S, Cakar ES, Buyukkagnici U, Karaer A, Danisman N. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J Obstet Gynaecol Res 2012; 38: 658-664.
19. Schneider D, Hernandez C, Farias M, Uauy R, Krause BJ, Casanello P. Oxidative stress as common trait of endothelial dysfunction in chorionic arteries from fetuses with IUGR and LGA. Placenta 2015; 36: 552-558.
20. McMahon K, Karumanchi SA, Stillman IE, Cummings P, Patton D, Easterling T. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. Am J Obstet Gynecol 2014; 210: 68.e1-68.e 4.
21. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770-775.
22. Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, Uzan S, Rondeau E. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004; 50: 1702-1703.
23. Jiang Z, Zou Y, Ge Z, Qing Z, Huang SY, Sun L. A role of sFlt-1 in oxidative stress and apoptosis in human and mouse preeclamptic trophoblasts. Biol Reprod 2015; 93: 73.
24. Öztürk E, Balat O, Acılmıs YG, Ozcan C, Pence S, Erel O. Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. J Obstet Gynaecol Res 2011; 37: 337-342.
25. Hilali N, Kocyigit A, Demir M, Camuzcuoglu A, Incebiyik A, Camuzcuoglu H, Vural M, Taskin A. DNA damage and oxidative stress in patients with mild preeclampsia and offspring. Eur J Obstet Gynecol Reprod Biol 2013; 170: 377- 380.
26. Choi HY, Kim SW, Kim B, Lee HN, Kim SJ, Song M, Kim S, Kim J, Kim YB, Kim JH et al. Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiol. PLoS One 2014; 9: e99421.